Abstract
Introduction
Acute poisoning is a common reason for presentation to hospital. With a few poisons analytical toxicology data can be important in establishing a diagnosis of poisoning and guiding treatment. Examples include iron, lithium, and paracetamol (acetaminophen). The availability of reliable analytical facilities can also assist in other clinical areas, such as assessing illicit drug use and the diagnosis and treatment of poisoning with environmental toxins such as lead, as well as in the management of incidents related to the accidental or deliberate release of chemicals into the environment (chemical incidents) and other aspects of chemical safety.
Many acutely poisoned patients are treated successfully without any contribution from the laboratory other than routine clinical laboratory tests. 1 This is true particularly for those cases where there is no doubt about the poison involved and when the results of an analysis would not inf luence therapy. At the other extreme, toxicological analyses can play a useful role if the diagnosis of poisoning or the nature of any poison(s) present is in doubt, the administration of certain antidotes is contemplated, or the use of active elimination therapy is being considered. 2, 3 Close collaboration between the analyst and the originator of the request is important if tests other than routine toxicological analyses are to be useful.
However, many requests for emergency toxicological investigations are, in fact, requests for advice on the diagnosis or management of poisoning. TOXBASE (www.toxbase.org) is a database that can be accessed at any time by registered users in the UK and Eire from any computer that has access to the Internet and is the first line source of poisons information for health care professionals in the UK.
If analyses are indicated, ideally liaison with the laboratory should commence before any specimens are collected in all but the most straightforward cases, as some analytes, toxic metals for example, require special precautions in specimen collection. 4 On the other hand, residues of samples held in a clinical chemistry laboratory or by other departments, for example in the emergency department (ED) refrigerator, can be invaluable if the possibility of poisoning is raised in retrospect.
Tests for poisons which a patient is thought to have taken and for which specific therapy is available will often take priority. However, a defined series of tests (a 'screen') is occasionally justified in the absence of clinical or other evidence to indicate the poison(s) involved. If possible this screen should be tailored to the poisons commonly encountered in a particular country -in Western Europe and North America, for example, drugs (often accompanied by alcohol) will have been taken by most poisoned patients admitted to hospital. However, pesticides, ethnic medicines, and poisonous animals or plants are major concerns in many other countries. Screening in such circumstances is particularly difficult since such a wide variety of compounds may be encountered and may be guided by clinical and circumstantial evidence as indicated below.
Diagnosis of Poisoning
In suspected acute poisoning the clinician must ask a number of questions that may aid diagnosis. In the case of an unconscious (comatose) patient, the circumstances in which the patient was found and whether any tablet bottles or other containers, or paraphernalia of substance abuse ('scene residues'), were present can be important. Unexplained confusion or coma in the absence of head injury is often due to poisoning, particularly in young adults. 5, 6 Blood glucose should be measured to © 2009 Rila Publications Ltd.
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exclude hypoglycaemia as the cause of coma. Convulsions may be due to poisoning. 7, 8 If the patient is conscious, information on the presence of poisons in the home or workplace may be available. The patient's past medical history (including drugs prescribed, mental health) may also be helpful.
The physical examination may indicate the poison or class of poison involved (Table 1) . Thus, the combination of pin-point pupils, hyper salivation, incontinence, and respiratory depression suggests poisoning with a cholinesterase inhibitor such as an organophosphorus (OP) insecticide. However, the value of this approach is limited if a number of poisons with different actions have been ingested. Moreover, many drugs have similar effects on the body, whilst some clinical features may be the result of secondary effects such as anoxia. Thus, if a patient is admitted with depressed respiration and pin-point pupils this strongly suggests poisoning with an opioid such as heroin, especially if needle marks are discovered. However, if the pupils are dilated then other hypnotic drugs such as glutethimide may be present, or cerebral damage due to hypoxia may have occurred secondary to respiratory depression.
Diagnoses other than poisoning must also be considered. Thus, coma may be caused by, for example, a cerebrovascular accident or uncontrolled diabetes as well as poisoning. Characteristic features traditionally associated with specific poisons may not be displayed depending on the dose taken, or the time-course of the episode. The availability of the results of biochemical and haematological tests is obviously important in these circumstances. Poisoning with certain compounds is sometimes misdiagnosed, especially if the patient presents in the later stages of poisoning. Examples include: cardiorespiratory arrest (cyanide), hepatitis (paracetamol), paraesthesia (thallium), progressive pneumonitis (paraquat), and renal failure (ethylene glycol).
The analytical diagnosis of paracetamol poisoning is especially important since within the first 24 h the clinical features of potentially fatal poisoning typically are unremarkable. However, antidotal treatment must be instituted promptly if it is to be effective. Serious paracetamol poisoning is rare in children. However, lifethreatening overdoses are common in adults in the UK and in the US. An emergency paracetamol assay should be considered on samples from all overdose or suspected overdose patients aged 10 years or more presenting at hospital. 2, 9 Especial difficulties may arise in deciding on treatment (i) if the patient has taken more than one paracetamol overdose in the preceding 48 h or so, and (ii) if either an overdose of a sustained release paracetamol preparation has been taken 10 , or paracetamol has been coingested with an opioid such as codeine or another drug that delays gastric emptying 11 because in such cases the standard interpretative nomogram may mislead.
Abdominal radiography may aid the diagnosis of poisoning, although a toxicological analysis is needed to establish the nature of the poison ingested if this is in doubt. Examples of radio-opaque poisons include enteric coated aspirin, ferrous sulphate, lead particles, sustained release potassium, and halogenated hydrocarbons such as chloroform and trichloroethylene. Radiography may also help detect and monitor movement of ingested batteries and of packages of illicit drugs which have been wrapped in aluminium foil or condoms. However, toxicological analyses are needed to monitor in vivo release of drug from such packages, or of mercury or other toxic metal ions from batteries, and may help indicate the need for surgical intervention.
Poisons 'Screening'
In clinical poisons screening the main aims are usually to detect poisons that act on the central nervous system (CNS) and to identify situations where active treatment of poisoning may be indicated. It may even be helpful to establish whether a clinical diagnosis of self-poisoning was correct in the face of denial of this possibility either from relatives, or indeed from the patient. The diagnosis of unauthorised drug administration to children or other dependents (Munchausen syndrome by proxy, induced illness) is a particularly specialised area with potentially farreaching implications. 12, 13 Advice should always be sought from the patient's consultant if this is suspected. Chain of custody procedures and rigorous documentation of the analyses are required. Toxicological analyses may also be important in establishing a diagnosis of Munchausen syndrome (self-induced illness), and in alleviating anxiety in patients who believe they have been poisoned by incidental exposure to, for example, pesticides even though there is no evidence for this belief.
All relevant information about a particular patient should be communicated to the analyst and appropriate specimens must be collected and properly labelled. Useful information might include the medical and social history, especially any history of substance abuse, treatment in hospital including drug therapy, and the results of laboratory and/or other investigations. It is also important to be aware of the timing of the sample(s) in relation to the time of the suspected ingestion or exposure as this may inf luence the interpretation of results. A request form must be completed to accompany the specimens to the laboratory with, as a minimum, adequate patient identification information and sufficient clinical information to guide the analyses.
A note of a patient's occupation or hobbies can be valuable as this may indicate access to particular poisons. Cyanide poisoning may result from accidents in electroplating establishments, for example, whilst poisoning with sodium barbital is now encountered most frequently amongst laboratory workers. Information on the drugs prescribed for the patient, and indeed the patient's relatives, is especially important as this may not only indicate the poison(s) ingested, but also warns that a compound detected may be a drug prescribed for the patient. Even compounds given inadvertently can cause serious toxicity in exceptional circumstances. Benzyl alcohol used as a preservative in intravenous (i.v.) f luids has caused fatal poisoning in young children. Iodine used intra-abdominally after surgery has resulted in death.
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Botulinum toxin and other toxins of microbiological origin are usually considered together with food poisoning. Poisoning from other naturally-occurring poisons, which include atropine from Atropa belladonna, solanine from potatoes, and cyanide from Cassava and from apple pips, also occurs. Here analysis of the foodstuff rather than biological samples can be more helpful in establishing the diagnosis in individual patients. Acute pesticide poisoning sometimes occurs after ingestion of contaminated produce and again analysis of the foodstuff can be helpful.
Traditional medicines have always been used widely in many parts of the world and are now being consumed in large quantities in Western countries. The analysis of herbal remedies, ethnic medicines, etc. is usually difficult as the ingredient(s) are often unknown except when undeclared pharmaceuticals such as steroids or inorganic poisons such as toxic metals are found to be present on testing using conventional procedures.
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Classification of Coma
Loss of consciousness (coma) is common in acute poisoning. The Glasgow Coma Scale (GCS) assesses three responses to stimuli: eye (E), verbal (V), and motor (M) ( Table 2 ). The GCS is scored between 3 and 15, 3 indicating no responses and 15 full (normal) responses. Note that the phrase 'GCS 11' is, strictly, meaningless as ideally the figure should be broken down into its components, such as E3V3M5 ϭ GCS 11. A GCS of 13 or higher suggests mild, 9 to 12 moderate, and 8 to 3 severe brain injury/impairment.
Treatment of Poisoning
When acute poisoning is suspected essential therapeutic measures are often taken before the diagnosis is confirmed. Thus, if the poison has been inhaled, the patient should be removed from the contaminated environment. If skin contamination has occurred, contaminated clothing should be removed and the skin washed with an appropriate f luid, usually water. Nowadays, gastric lavage (stomach washout) is rarely indicated in adults and contraindicated in children, but absorption of ingested drugs and other organic poisons may be minimised by oral dosage with a slurry of activated charcoal if the patient presents within an hour or so of ingestion. However, oral charcoal should NOT be given when oral administration of protective agents, such as methionine following paracetamol over dosage, is contemplated. Induction of emesis by use of sodium chloride solution or syrup of ipecacuanha (ipecac) is contraindicated due to the risk of (i) absorption of the emetic, and (ii) inhalation of vomit.
Treatment of severely poisoned patients may include IV administration of anticonvulsants such as diazepam or thiopental, or of antiarrhythmics such as lidocaine (lignocaine), all of which may be detected if a toxicological analysis is performed subsequently. Antidotes such as naloxone and antibiotics such as metronidazole or trimethoprim may also be detected. Lidocaine gel or spray is used as a topical anaesthetic and is often an incidental analytical finding after use, for example, during bladder catheterization or upper gastrointestinal endoscopy. Acute poisoning with oral or IV lidocaine also occurs, and thus interpretation of the finding of lidocaine must be undertaken cautiously.
Drugs or other compounds may also be given during first aid or investigative procedures such as lumbar puncture or computerized tomographic (CT) scans and in turn may be detected on subsequent toxicological analysis. Iodinated benzoic acid derivatives are used as X-ray contrast media. The muscle relaxant atracurium, which gives rise to laudanosine in vivo, is frequently given to facilitate mechanical ventilation. Even emetine from ipecac given to induce vomiting has been detected on subsequent analysis of urine. It is therefore important that details of ALL drugs used in therapy are notified to the laboratory at the time of the initial request.
Antidotes
Antidotes are only available for a limited number of poisons (Table 3) . Controversy surrounds the use of some antidotes such as those used to treat cyanide poisoning, while others are potentially toxic and must be used with care. Lack of response to a particular antidote must not be used to indicate the absence of particular poisons. For example, the opioid antagonist naloxone will rapidly and completely reverse coma due to opioids such as morphine and codeine without risk to the patient, except that an acute withdrawal response may be precipitated in dependent subjects. However, a lack of response does not always mean that no opioids are present since another, non-opioid, drug may be the cause of coma, too little naloxone may have been given, or hypoxic brain damage may have followed a cardiorespiratory or respiratory arrest. Eyes open spontaneously (4) No verbal response (1) Incomprehensible sounds (2) Inappropriate words (3) Confused (4) Orientated (5) No motor response (1) Extension to pain (2) Flexion to pain (3) Withdrawal from pain (4) Localising pain (5) Obeys commands (6) (i) repeated oral activated charcoal, (ii) alkalinisation, (iii) peritoneal dialysis and haemodialysis/haemofiltration, and (iv) plasmapheresis. An additional technique, haemoperfusion, in which blood is pumped through a cartridge of adsorbent material (coated activated charcoal or Amberlite XAD-4 resin), was considered to have benefit in barbiturate poisoning, for example. However, haemoperfusion is of dubious efficacy in treating acute poisoning and is rarely used nowadays for this purpose.
Active Elimination Therapy
In severe poisoning the elimination of compounds such as barbiturates, carbamazepine, quinine, and theophylline (and possibly also salicylates) may be enhanced by giving oral activated charcoal when the patient presents and thereafter at 4-6 hr intervals until clinical recovery is apparent. To reduce transit time and thus reabsorption of the poison, the charcoal is often given together with a laxative. This procedure has the advantage of being non-invasive, but is less effective if the patient has a paralytic ileus due the ingestion of, for example, phenobarbital. Care must also be taken to avoid pulmonary aspiration in patients without a gag reflex or in those with a depressed level of consciousness. Repeatdose charcoal is unlikely to be effective with poisons with a large volume of distribution such as cardiac glycosides and tricyclic antidepressants (TCAs). 
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The aim of alkalinization is to produce ionization of acidic poisons and thus (i) favour partition from tissues into blood hence minimizing toxicity and (ii) enhance urinary excretion by preventing reabsorption in the renal tubules. Thus, elimination of chlorophenoxy herbicides and salicylates may be increased by the IV administration of sodium bicarbonate. However, the pK a of the poison must be such that renal elimination can be enhanced by alterations in urinary pH within the physiological range, and it is important to monitor urine pH carefully to ensure that the desired pH change has been achieved and is maintained. Acidification of urine was thought to enhance the clearance of weak bases such as amphetamines, procyclidine, and quinine, but this is no longer accepted. Forced diuresis (administration of excess f luid to increase urine output) is no longer used due to (i) lack of efficacy and (ii) the risk of f luid overload leading to cerebral and pulmonary oedema.
In haemodialysis, blood is passed over a semi-permeable membrane that is in contact with a large volume of dialysis f luid, while in peritoneal dialysis an appropriate f luid is infused into the peritoneal cavity and then drained some 2-4 hr later. In both cases transfer of poison is by simple diffusion. Peritoneal dialysis is slower and less efficient than haemodialysis, but does not require special apparatus.
Haemodialysis is preferred for water-soluble substances such as ethanol and lithium ion. The decision to use dialysis should be based upon the clinical condition of the patient, the properties of the poison ingested, and its concentration in plasma. Haemodialysis is only effective when the volume of distribution of the poison is relatively small, i.e. less than 5-6 L kg -1 , and plasma protein binding is minimal. Haemofiltration works on the same principle as haemodialysis. Thus, blood is passed through tubing (a filtration circuit) to a semi permeable membrane (the filter) where waste products and water are removed. Replacement f luid is added and the blood is returned to the patient.
Plasmapheresis is a process in which, in simple terms, plasma is separated from blood cells outside the body by centrifugation. The cells are returned to the patient, while the plasma containing the poison is either purified and returned to the patient, or discarded and replaced with donor plasma or with isotonic sodium chloride with added protein. An anticoagulant is given through a vein during the procedure. Exchange transfusion is sometimes used if plasmapheresis is not feasible, and involves the incremental removal of the patient's blood and replacement with fresh donor blood or plasma. These procedures are only justified in very serious cases when supportive measures are clearly failing. 
Clinical Laboratory Tests and the Poisoned Patient
Poisoning often results in metabolic disturbances, which may be life-threatening, and may be characteristic of particular poisons (Table 1) . 17 There are consensus guidelines as to the support routine clinical chemistry and haematology can provide in the diagnosis and treatment of poisoning. 2 A number of clinical laboratory tests may be useful in the diagnosis and treatment of poisoning (Table 4) . Physical examination of the specimen may yield valuable information. However, appropriate toxicological investigations will usually be needed to confirm such findings. Chocolate-brown venous blood indicates severe methaemoglobinaemia from exposure to oxidizing agents such as nitrites. Cherry-pink blood is said to be linked to carbon monoxide poisoning, but is rarely observed in clinical practice. Pink/brown coloured plasma from a carefully collected sample suggests haemolysis and thus possible poisoning with compounds such as arsine, chlorates, or dapsone. Orange plasma has been described after ingestion of canthaxanthin as a sun-tanning aid.
Glucose
Marked hypoglycaemia may result from over dosage with insulin, sulfonylureas such as tolbutamide, or other antidiabetic drugs. Use of these drugs in normoglycaemic individuals may prove fatal. Hypoglycaemia may also follow ingestion of salicylates, ethanol (especially in children or fasting adults), •-adrenoceptor blocking drugs, and venlafaxine, and may also complicate severe poisoning due to a number of hepatotoxins including paracetamol, chlorinated hydrocarbons such as chloroform, isoniazid, phenylbutazone, iron salts, valproate, and certain fungi. Hypoglycin is a potent hypoglycaemic agent found in unripe akee (Blighia sapida) fruit and is responsible for Jamaican vomiting sickness.
Hyperglycaemia is usually due to stimulation of the sympathetic nervous system as in theophylline poisoning, and has been reported after exposure to a range of other compounds (Table 5 ).
Blood Gases and pH: the Anion Gap
Coma due to poisoning with hypnotic, sedative, antipsychotic, or opioid drugs is often characterized by hypoxia and respiratory acidosis. Unless appropriate treatment is instituted, however, a mixed respiratory and metabolic acidosis will supervene. In contrast, over dosage with salicylates initially causes hyperventilation through a direct effect on the respiratory centre resulting in respiratory alkalosis, and the risk of hypokalaemia. A mixed acid-base disturbance (the metabolic acidosis results from the presence of acidic metabolites such as salicylic acid) is characteristic.
The anion gap is the difference between the measured cations, sodium and potassium, and the measured anions, bicarbonate and chloride (all mmol/L).
The anion gap is normally about 12 mmol/L and is made up of unmeasured anions such as phosphate, sulfate, and some organic acids. In metabolic acidosis (blood pH Ͻ7.35) the gap is raised due to an increase in the unmeasured cations ϪH ϩ is present in millimolar concentrations, barely affecting the unmeasured cations, but there is an increase in the anion lactate buffered by bicarbonate.
Low values of the anion gap most commonly indicate laboratory error or hypoalbuminaemia, but can denote the presence of a paraproteinaemia or intoxication with lithium ion, bromide, or iodide. 18, 19 Metabolic acidosis can be divided into high anion and normal anion gap varieties, which can be present alone or concurrently. Elevated values most commonly indicate metabolic acidosis, but can ref lect laboratory error, metabolic alkalosis, hyperphosphataemia, or paraproteinaemia. In poisoning with carbon monoxide, cyanide ion, ethanol, ethylene glycol, f luoroacetates, iron salts, ionized, metformin, methanol, paraldehyde, 1,2-propanediol (propylene glycol), or salicylates the anion gap typically exceeds 15 mmol L -1 . 20 The metabolic acidosis in ethylene glycol poisoning is due to metabolism to glycolate. Chronic toluene abuse can give rise to a severe metabolic acidosis with a high anion gap, possibly due to the accumulation of ketoacids and benzoate. Tolueneinduced distal renal tubular (Type 1) acidosis (normal anion gap) has also been described. Massive propylene glycol administration has been reported as a cause of D-lactic acidosis.
21,22
Electrolytes
Electrolyte disturbances occur after exposure to a variety of poisons. Such disturbances may appear simple to monitor and to interpret, but are often complex. The correct interpretation of serial measurements requires a detailed knowledge of the therapy administered. The 
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consequences of electrolyte imbalances depend on many factors including the pharmacological effect of the drug on water and electrolyte homeostasis, the state of hydration, and renal function. There may be concomitant or compensatory changes in other electrolytes.
Hyponatraemia is far more common than hypernatraemia as a direct effect of poisoning. Naturesis induced by diuretics is common in therapy, and dilutional hyponatraemia may be due to water intoxication, including patients recovered from fresh water immersion, as well as those ingesting large amounts of f luid chronically. 23 Use of methylenedioxy methamphetamine (MDMA, ecstasy), or inappropriate vasopressin activity associated with a number of drugs may also be associated with hyponatraemia.
MDMA, on the other hand, has also been associated with malignant hyperthermia resulting in acute dehydration and hypernatraemia. Diabetes insipidus resulting in hypernatraemia is an unusual complication of lithium poisoning. Hypernatraemia may also occur after deliberate administration of sodium chloride to children, which may prove fatal. Distinguishing between salt poisoning and hypernatraemic dehydration in such cases may not be straightforward. 24 Poisons associated with either hyperkalaemia, or hypokalaemia are listed in Table 6 . Hypokalaemia usually results from stimulation of the cell membrane sodium/ potassium pump leading to increased tissue potassium concentrations. Hypokalaemia and metabolic acidosis are features of theophylline and salbutamol overdose. Hypokalaemia and metabolic alkalosis can be caused by chronic abuse of diuretics, laxatives, or sodium bicarbonate/sodium bicarbonate-containing mixtures. 25, 26 Hypokalaemia may also be a feature of paracetamol overdosage. 27 Potentially fatal hypocalcaemia can occur after ingestion of ethylene glycol or of oxalates such as oxalic acid due to chelation of calcium, which can cause brain, muscle, and kidney damage due to deposition of calcium oxalate. Hypocalcaemia may also occur as a result of acute poisoning with f luorides. Hypermagnesaemia is usually attributable to ingestion of magnesium salts.
Osmolality
Plasma osmolality can (i) be measured easily by freezing point depression and (ii) estimated using the equation below:
The normal osmolality of plasma (280300 mmol kg Ϫ1 water) is largely accounted for by the sum of the sodium, urea, and glucose concentrations. 28 Differences between measured and estimated osmolality can indicate the 30 using an enzymic ethanol assay Table 7 : Effect of some common poisons on plasma osmolality.
(1,2)
presence of additional osmotically active substances. Large increases in plasma osmolality may follow the absorption of osmotically active poisons, i.e. compounds with a relative molecular mass (M R ) Ͻ150, notably methanol, ethanol, or 2-propanol, in relatively large amounts, or the IV administration of hypertonic solutions of mannitol, for example. Ethylene glycol, acetone, and some other low M R organic substances are also osmotically active in proportion to their molar concentration. These substances do not behave as ideal solutes in plasma, therefore plasma concentrations of these compounds can only be estimated from the measured osmolality, even after adjustment for changes in the proportion of water in plasma (Table 7) . 29, 30 Although the measurement of plasma osmolality and calculation of the osmolal gap (measured osmolality -calculated osmolality) may give useful information, interpretation can be difficult. 31 It is important therefore that toxicological analyses are performed in order to confirm any provisional diagnosis. Comparison with the anion gap will indicate whether an ionic compound has caused a raised osmolar gap rather than an osmotically active molecule such as ethanol. Note that a normal plasma osmolality does not exclude severe poisoning with ethylene glycol or methanol.
Plasma Enzyme Activity
Shock, coma, or convulsions are often associated with nonspecific increases in plasma or serum activities of aspartate aminotransferase (AST) and alanine aminotransferase (ALT), primarily of hepatic origin, and of lactate dehydrogenase (LDH), either of hepatic or cardiac origin. Following the initial insult the plasma activities of these enzymes may increase over a few days and, provided that there is no continuing tissue damage, return to normal at a rate consistent with the plasma halflife of the enzyme.
The magnitude of the change in these parameters indicates the extent of damage and may be of diagnostic or prognostic value with specific poisons. Plasma AST and ALT, for example, may increase substantially in severe poisoning with paracetamol, chloroform, 1,2-dichloropropane (propylene dichloride), and copper salts. 32 Typically this process will commence within 48 hours and peak several days later if fulminant hepatic failure does not supervene. It may take several weeks for values to return to normal. Plasma AST and ALT activities may also be raised in patients on chronic therapy with drugs such as sodium valproate. Serious hepatotoxicity may develop in a small proportion of these latter patients. Excessive long-term ethanol use is usually associated with increased plasma •-glutamyl transferase (•-GT, GGT) activity.
In very severe poisoning, especially if a prolonged period of coma, convulsions, hypothermia, or shock has occurred, there is likely to be clinical or sub-clinical muscle injury associated with rhabdomyolysis and disseminated intravascular coagulation (DIC). Such damage may also occur as a result of chronic parenteral abuse of psychotropic drugs. Frank rhabdomyolysis is characterized by high serum creatine kinase (CK) activity together with myoglobinuria. A high CK, thirty times the upper limit of normal, is consistent with rhabdomyolysis, and in such cases there is no need to detect myoglobin in the urine. 33 In serious cases of poisoning, with theophylline or strychnine for example, or after a prolonged period of convulsions, the resultant myoglobinuria can lead to acute renal failure.
Cholinesterase Activity
Systemic toxicity from carbamate and OP pesticides and nerve agents is due largely to inhibition of acetyl cholinesterase (acetylcholine acetylhydrolase, EC 3.1.1.7) in nerve synapses. Butyrylcholinesterase (acylcholine acylhydrolase, EC 3.1.1.8), also known as pseudocholinesterase, derived initially from the liver, is also present in plasma, but inhibition of plasma cholinesterase is not thought to be physiologically important. Butyrylcholinesterase and acetylcholinesterase are different enzymes: plasma cholinesterase may be almost completely inhibited while acetylcholinesterase itself may still possess 50 % activity. This relative inhibition varies between different compounds and with the route of absorption, and depends on whether exposure has been acute, chronic or acute on chronic. In addition, individual carbamates and OP insecticides differ in the rate at which (acetyl) cholinesterase inhibition is reversed after acute exposure. Depression of erythrocyte acetylcholinesterase can persist for several weeks post-exposure, whereas plasma cholinesterase recovers much more quickly. Specimens obtained post mortem for acetylcholinesterase assay must be kept cold and analysed as soon as possible to minimize spontaneous reactivation of the enzyme.
In practice, plasma cholinesterase is a useful indicator of exposure to OP insecticides or carbamates, and a normal plasma cholinesterase activity effectively excludes serious poisoning by these compounds. The difficulty lies in deciding whether a low activity is indeed due to poisoning or to some other physiological, pharmacological, or genetic cause. The diagnosis can sometimes be assisted by detecting a poison or metabolite in a body f luid. Alternatively pralidoxime, used as an antidote in poisoning with OP insecticides, may be added to a second portion of the sample at an appropriate concentration and the cholinesterase assay repeated. If the inhibition of cholinesterase activity is reversed by pralidoxime this suggests the presence of a cholinesterase inhibitor in the sample.
Red cell acetylcholinesterase activity can be measured, but this enzyme is membrane-bound and the apparent activity depends upon the methods used in solubilisation and separation from residual plasma cholinesterase. Alternatively quinidine sulphate can be added to inhibit plasma cholinesterase whilst red cell acetylcholinesterase is being measured (34) . Red cell acetylcholinesterase activity also depends on the rate of erythropoiesis and is thus a better marker of exposure to cholinesterase inhibitors. Newly-formed erythrocytes have a high activity, which diminishes with time. Hence red cell acetyl cholinesterase activity is a function of the number and age of the cell population. However, if the activities of both plasma cholinesterase and red cell acetylcholinesterase are low, the © 2009 Rila Publications Ltd.
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likelihood of poisoning due to either OP insecticides or carbamates is strong.
Several genotypes of plasma cholinesterase are known. The frequency of the usual form is 94%. An atypical form which results in a prolonged duration of action of suxamethonium is widely distributed (1:2800). The duration of action of suxamethonium is normally about 6 minutes, but those with the atypical enzyme may be paralysed for over 2 hours and require respiratory support until the drug is eliminated by other routes. Individuals at risk can be identified from their family history and the susceptibility of their cholinesterase to the local anaesthetic dibucaine, which does not inhibit the atypical form as much as it inhibits the normal form. Individuals in the UK identified as having the atypical form of the enzyme have for many years carried cards identifying their status. As with other significant genetic polymorphisms, the status of family members should be investigated if these are not already known.
Methods for plasma cholinesterase and whole blood acetylcholinesterase are given in Moffat et al. 35 The kinetic method for acetylcholinesterase 34 requires use of automated equipment since accurate absorption measurements at different time points are required. Kits for measuring plasma cholinesterase or erythrocyte, whole blood, or plasma acetyl-cholinesterase activity are also available (EQM Research, http://www.eqmresearch.com/). Normal values for serum cholinesterase range from 1900-4000 U L -1 and normal values for whole blood acetylcholinesterase range from 3500-8000 IU mL -1 . However, the normal ranges for acetylcholinesterase are highly method-dependent and there are wide variations between methods.
Mast Cell Enzymes
Many drugs/drug types may precipitate anaphylaxis or anaphylactoid reactions. It has been suggested that mast-cell tryptase activity can be used as an indicator of anaphylactic shock. Mast-cell tryptase was increased in 158, equivocal in 10, and not increased in 182 patients with anaphylactic reactions during anaesthesia. 36 It has been suggested that another mast-cell enzyme, chymase, can be used as an indicator of anaphylactic shock in post-mortem work. 37 
Blood Clotting
Prolongation of the prothrombin time (normally expressed as a ratio to a control, International Normalized Ratio, INR), is the earliest indicator of hepatic damage most notably after poisoning with paracetamol, but also after exposure to certain chlorinated hydrocarbons, isoniazid, iron salts, phenylbutazone and certain fungi, notably Amanita phalloides. The INR and other measures of blood clotting are likely to be abnormal in poisoning with warfarin and related compounds (for example, brodifacoum), and after over dosage with heparin. Coagulopathies may also occur as a side effect of antibiotic therap y. DIC occurs commonly after bites from poisonous snakes, and has been reported in severe poisoning with monoamine oxidase inhibitors (MAOIs), with phencyclidine, with amphetamines and related stimulants, and with a range of other compounds if associated with prolonged coma, convulsions, or shock (Section 4,5).
Carboxyhaemoglobin and Methaemoglobin
Non-specific neurological signs, such as headache and confusion, sometimes affecting several family members, may be caused by carbon monoxide poisoning, perhaps from a faulty gas appliance. Blood carboxyhaemoglobin (HbCO) measurement is helpful in assessing the severity of carbon monoxide exposure in such cases. 38 However, HbCO is dissociated especially rapidly if normobaric oxygen rather than atmospheric air is administered in therapy, and thus the sample should be obtained as soon as possible after admission. Even then, blood HbCO correlates poorly with clinical features of toxicity after acute poisoning (Table 8 ). Blood HbCO measurements are also used in monitoring exposure to halomethanes such as dichloromethane (some 30 % of absorbed dichloromethane is metabolised to carbon monoxide).
Methaemoglobin (oxidized haemoglobin) may be formed after ingestion of dapsone, phenacetin, and strong oxidizing agents such as chlorates, nitrates, and nitrites [including aliphatic nitrites such as isobutyl and isopentyl (amyl) nitrites]. Methaemoglobinaemia can also be induced by exposure to aniline and to aromatic nitro-compounds such as nitrobenzene and some of its derivatives. Methaemoglobinaemia has also been observed after zopiclone ingestion, possibly secondary to zopiclone N-oxide formation. 39 Methaemoglobinaemia may be indicated by the presence of dark chocolate-coloured blood. Blood methaemoglobin can be measured, but is unstable and the use of stored samples is thus unreliable. An emergency measurement helps assess the magnitude of exposure and inter alia the decision to treat with the redox reagent methylene blue, which in appropriate dosage can reduce methaemoglobin to haemoglobin.
Haematocrit
Acute or acute on chronic poisoning with ethanol, iron salts, and indometacin, salicylates and other nonsteroidal anti-inf lammatory drugs (NSAIDs), can cause gastrointestinal bleeding leading to anaemia. Anaemia may also result from chronic exposure to compounds that interfere with haem synthesis, such as lead, or which induce haemolysis either directly (arsine, stibine) or indirectly because of glucose-6-phosphate dehydrogenase 
Analytical Toxicology Assay Availability: Hospital Laboratories
Requests for toxicological analyses tend to fall into (i) emergency and general hospital toxicology, including Јpoisons screeningЈ, and (ii) more specialised categories such as screening for drugs of abuse, therapeutic drug monitoring (TDM), and metals/trace elements analyses. However, there is considerable overlap between all of these areas. Recommendations as to the assays that should be provided locally and at regional centres have been published from the UK 2 and US 3 and are generally applicable. Tests for poisons for which specific therapy is available (Table 9) will normally be given priority. More complex, less frequently needed assays that can often be offered on a less urgent basis (Table 10 ) are usually provided from regional or national centres because of the need to make best use of resources.
Clinical Toxicology
The range of analyses that can be offered by specialised laboratories, sometimes on an emergency basis, usually encompasses several hundred poisons. ЈPoisons screensЈ must use reasonable amounts of commonlyavailable samples (20-30 mL urine, 2-5 mL plasma or 5-10 mL whole blood). If any tests are to inf luence immediate patient management, the (preliminary) results should be available within 2-3 hr of receiving the specimens (1hr in the case of paracetamol). In some cases the presence of more than one poison, for example, may complicate the analysis and examination of further specimens from the patient may be required.
Analytical Methods
A simple poisons screen requiring a minimum of analytical equipment consists of TLC of acidic and basic extracts of urine together with a number of simple colour tests e.g. tests for salicylates, paracetamol, and trichloro-compounds. TLC is capable of detecting a wide range of centrally acting drugs, and sample preparation can be simplified if pre-buffered liquid-liquid extraction tubes (Varian, Palo Alto, CA. Diatomaceous earth products: Chem Elut) are used since acidic, and basic drugs and free morphine can be extracted simultaneously. Toxi-Lab (Varian) is a standardized thin-layer chromatography (TLC) system that is available in kit form together with a compendium of colour plates showing R f values, colour reactions, and additional information to facilitate interpretation (AB System). Cellulose impregnated with silica takes the place of the conventional TLC plate -a practical advantage is that dipping in visualization reagents can be used obviating the need for a fume hood. The ЈscreenЈ can be supplemented by immunoassays for common drugs of abuse if these are available. However, a major limitation is that TLC and colour tests are not amenable to quantitative work which, to be of value, usually has to be performed in whole blood or plasma/serum.
Analytical methods used in regional laboratories will to an extent again be dependent on local circumstances, but ideally facilities for TLC, high performance liquid chromatography (HPLC), and gas chromatography-mass spectrometry (GC-MS) and possibly high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) will be needed. In addition, atomic absorption spectrophotometry or inductively-coupled mass spectrometry (ICP-MS) will be required for metals/ trace elements analysis. 4, 35 Analytical toxicology laboratories rely on GC to screen for and measure blood ethanol and this has the advantage that the method can detect and measure other alcohols (methanol, 2-propanol) if necessary. GC of blood or urine extracts using a capillary column with selective detection (nitrogen-phosphorus or MS) after acidic and basic extraction is also the cornerstone of screening for organic poisons such as many drugs and pesticides. 41, 42 HPLC coupled with diode-array detection is also a useful screening procedure. 43 At present LC-MS, whilst used for screening for screening for drugs of abuse, for example, still has some drawbacks in routine use. 44 The effects of coeluted compounds on analyte response ('matrix effects') can be unpredictable, for example, whilst heated ion sources can cause thermal decomposition of the analyte.
Clinical Considerations
Circumstantial evidence of the compound(s) involved in a poisoning episode is often ambiguous and thus, on the rare occasions when an analysis for 'poisons' is indicated, it is advisable to perform a 'poisons screen' routinely in all but the simplest cases. Similarly, the analysis should not end after the first positive finding because additional, hitherto unsuspected compounds may be present. One exception is provided by sub-lethal carbon monoxide poisoning which can be difficult to diagnose even if carboxyhaemoglobin measurements are available -circumstantial evidence of poisoning may prove invaluable in such cases. Of course, a 'positive' result on a 'poisons screen' does not of itself confirm poisoning because such a result may arise from incidental or occupational exposure to the poison in question or the use of drugs in treatment.
Blood is often the easiest specimen to obtain from an unconscious patient and is needed for any quantitative measurements (Table 11) . Urine is also a valuable specimen as drug or metabolite concentrations tend to be higher than in blood and relatively large volumes may be available. However, some compounds such as many benzodiazepines are extensively metabolised prior to excretion and then plasma is the specimen of choice for detecting the parent compound. Quantitative measurements in urine are generally of little use in emergency toxicology except that if poisoning with •-hydroxybutyrate (•-hydroxybutyric acid, GHB) or its precursor •-butyrolactone (GBL) is suspected, a urine cut-off of 10 mg L -1 is recommended to differentiate between endogenous GHB excretion and exogenous GHB or GBL administration. 45 An adjunct to the normal poisons ЈscreenЈ that is undertaken in some laboratories is so-called Јbrain deathЈ screening. If a patient is thought to have suffered irreversible hypoxic/anoxic brain damage a decision on withdrawing mechanical ventilation may have to be taken. If the hypoxic insult was attributable to poisoning with a drug such as a barbiturate, or compounds such as midazolam or thiopental have been given in treatment, then the question of ensuring the absence of centrally-acting drugs before proceeding becomes important. Toxicological analysis using appropriately validated methodology (reliability, detection limit, etc.) is one way of obtaining the required information. All poisons screens have limitations. Thus, of the drugs commonly used to treat mental illness, lithium has to be looked for specifically, whilst those MAOIs that act irreversibly, such as phenelzine, have a prolonged action in the body even though plasma concentrations may be very low after over dosage. Any drug that is not bound to the enzyme may be excreted rapidly and may be difficult to detect except in a urine specimen obtained soon after the event. On the other hand, TCAs are very lipophilic and urinary concentrations, even after fatal poisoning, may be below the LoD of the analytical method if death has occurred relatively soon after an ingestion.
For rapid paracetamol assay simple colorimetric enzyme-based methods are commonly used. One method is based on the use of an enzyme specific for the amide bond of acylated aromatic amines. It cleaves the 
/DMPS (4) Arsenic Bismuth Mercury 100 µg L Ϫ1 (whole blood) (5) 100 µg L Ϫ1 (whole blood) 100 µg L Ϫ1 (whole blood)
Immunotherapy
Antidigoxin Fab antibody fragments Digoxin (6) 6 µg L Ϫ1 (7.6 nmol L Ϫ1 )
Active Elimination
Oral Prussian Blue (7) Thallium 100 µg L Ϫ1 (whole blood)
Alkaline diuresis Chlorophenoxy herbicides
Key: 1. Many factors may modify response in a given patient 2. Calcium disodium ethylenediaminetetra-acetate 3. meso-2,3-Dimercaptosuccinic acid 4. Sodium 2,3-dimercaptopropane sulfonate 5. Recent ingestion of fish or shellfish renders total arsenic measurements meaningless 6. May also be used to treat poisoning with other cardiac glycosides such as digitoxin 7. Potassium ferrihexacyanoferrate [iron(III) hexacyanoferrate(II)] 
Laboratory Support for the Poisoned Patient
paracetamol molecule, yielding 4-aminophenol, which reacts specifically with o-cresol in ammoniacal copper solution to give a blue colour that can be measured spectrophotometrically. In practice such methods are commonly automated, but it is important to keep the ratio of sample to colour reagent similar to that of the manual assay to minimise the risk of interference from N-acetylcysteine in the event that the blood sample was collected after antidote administration. Note also that colorimetric paracetamol assays may still suffer from interference from bilirubin especially -this can give rise to a false assumption of paracetamol administration which may be important, for example if the patient is a child. 46 Insulin is initially synthesized as proinsulin, a form of insulin in which the •-and •-chains of insulin are linked to a third polypeptide chain (connecting peptide, C-peptide). Hydrolysis of proinsulin in the pancreas leads to secretion of insulin and c-peptide in equimolar amounts. Thus, in theory plasma insulin and C-peptide can be measured and the ratio of the two analytes used as an indicator of endogenous insulin production when exogenous insulin, which lacks C-peptide, may have been given. 4 Ethylene glycol is used mainly in radiator antifreeze as a concentrated (20-50 % v/v) aqueous solution, sometimes together with methanol. Methanol is also used as a general and laboratory solvent, and in windscreen washer additives, duplicating f luids, and in illicit alcoholic drinks. Ethylene glycol and methanol are themselves relatively non-toxic, but metabolism by alcohol and aldehyde dehydrogenases gives rise to glycolic and oxalic acids, and formaldehyde and formic acid, respectively.
Laboratory support for patients poisoned with toxic alcohols [notably methanol, ethylene glycol, diethylene glycol (2-hydroxyethoxy)ethan-2-ol], 1,2-propanediol, and 2-propanol} remains difficult. 47 The severity of acute poisoning with ethylene glycol and with methanol is best assessed in the early stages by measurement of plasma concentrations, although treatment should not be delayed if an emergency analysis is not available. Measurement of plasma ethanol is also useful if ethanol is used to treat methanol or ethylene glycol poisoning to ensure that effective plasma concentrations (ca. 1 g L
Ϫ1
) of the protective agent are maintained. The alcohol dehydrogenase inhibitor fomepizole (4-methypyrazole, 4-MP) is becoming more widely available and has the advantage that administration is simple as it has a relatively long plasma half-life and is not removed by haemodialysis.
In addition to the presence of a metabolic acidosis, a rise in plasma osmolality is a useful albeit non-specific early indicator of poisoning with toxic alcohols (Section 4.4). Oxalic acid may be excreted in urine as calcium oxalate dihydrate, and the crystalluria produced may be diagnostic in ethylene glycol poisoning. Checking for urine f luorescence attributable to the presence of f luorescein added to some commercial antifreeze products may also help. Nitromethane interference in the Jaffe creatinine assay has also been exploited as a surrogate for plasma methanol assay after ingestion of model car fuel. 48, 49 Simple tests for methanol in gastric contents/scene residues and in urine have been described. A qualitative microdiffusion procedure for plasma methanol and ethylene glycol has also been reported. 50 However, GC is the ideal method for measuring unchanged ethylene glycol and/or methanol, and can also be used to measure ethanol. Poisoning with 1,3-propanediol, which is often used as the internal standard in ethylene glycol assay, has been described. 51 Enzyme-based procedures for ethylene glycol and methanol that can be automated have been described, although none are available commercially. An enzymebased assay for serum formate has also been described, 52 but suffers from the disadvantage that toxic metabolite formation must have already occurred if a positive result is obtained. In a similar vein, glycolate (and possibly glyoxylate) interference in lactate assay has been used as a surrogate for plasma ethylene glycol measurement 53 , although not all lactate assays show this effect. 54 Liquidbased tests that detect selectively methanol, ethylene glycol, diethylene glycol, and ethanol in saliva have been described. 55 Good sensitivity is claimed, but data on the clinical utility of these tests are lacking as yet.
Substance Abuse
The value of blood, breath, or urinary measurements in the diagnosis of ethanol abuse and in monitoring abstinence is clear. Screening for drugs of abuse in urine is also valuable in monitoring illicit drug taking in dependent patients and guards against prescribing controlled drugs for patients who are not themselves dependent. These tests may also be valuable in assessing patients presenting with no overt history of drug abuse. In addition, the diagnosis of maternal drug abuse either during pregnancy or post-partum can be important in the management of the neonate. Ingestion of laxatives and diuretics in order to produce weight loss is not uncommon and can be difficult to diagnose. Collection of serial urine samples over several days is advisable. Detection of the abuse of osmotic laxatives such as lactulose and bulk-formers such as bran is not possible analytically. The covert ingestion or administration of anti-coagulants such as warfarin is also well documented and can provide a difficult diagnostic problem.
The need for screening for the presence of illicit drugs in personnel in sensitive positions (armed forces, security services, pilots, drivers) or those applying for such positions ('employment' and 'pre-employment' screening, respectively), is now accepted. The detection of illicit drug administration in sport has also assumed importance. In animal sports the definition of an illicit compound is much easier than in man and can include any substance not normally derived from feedstuffs. In humans the illicit drugs encountered most commonly are opiates [mainly heroin (diacetylmorphine, diamorphine)], barbiturates, benzodiazepines (notably temazepam), cocaine, amphetamines including methylenedioxy methamphetamine (MDMA, 'ecstasy') and analogues which may include the highly toxic bromodragonf ly (BDF), and cannabis. Other compounds such as •-hydroxybutyrate (GHB) and its precursor •-butyrolactone (GBL), and benzylpiperazine (BZP) and analogues also occur.
The purity of 'street' drugs varies widely -heroin may be between 2 and 95 % pure, for example. Over dosage either with excessively pure 'street' drug or with drug 'cut' with a particularly toxic compound are possible causes of acute poisoning 'epidemics'. Barbiturates may be encountered either as a result of abuse per se or when mixed with other substances such as heroin. Paracetamol, phenacetin, strychnine, lidocaine, quinine, and/or chloroquine may be used to 'cut' street drugs. Serious acute poisoning may occur if tolerance has been reduced through abstinence. Methadone is widely used to treat opioid addiction, although use of buprenorphine for this purpose is now more frequent. Other opioid agonists such as codeine, dihydrocodeine, and pethidine also occur. The need to confirm buprenorphine ingestion in opioid withdrawal presents problems as the urinary concentrations of buprenorphine and metabolites attained may be relatively low, and interference from, for example, codeine, dihydrocodeine, tramadol 56 and amisulpride and sulpiride in the CEDIA urine buprenorphine test has been documented.
When screening for illicit drug use urine is the specimen of choice in most cases, not only because the concentrations of the compounds of interest tend to be higher than in blood, but also because it is easier to obtain, especially from patients likely to have damaged veins. Moreover, human urine presents less of a hazard than blood to laboratory staff. Although urine collection in conscious patients is non-invasive there are privacy issues surrounding collection. Saliva has been investigated extensively as an alternative matrix especially as regards roadside testing. The pattern of metabolites detected tends to differ from that seen in urine, but sensitivity is similar.
The availability of a variety of immunoassay kits has proved invaluable, especially in employment and preemployment screening when large numbers of negative results are to be expected and high sensitivity is required. In all cases it is necessary to confirm immunoassay results using a second, independent analytical technique if the results are to have reliability for forensic purposes. TLC and increasingly LC-MS are important because they can resolve controlled drugs such as morphine from opioids such as codeine or pholcodine that are available without restriction in many countries. TLC may require little in the way of capital investment, and is amenable to batch processing of samples. Capillary GC remains valuable in the detection and identification of amphetamines and in the confirmation of TLC results. An increasing number of laboratories are using LC-MS/MS (tandem MS) and dispensing with a preliminary immunoassay screen. LC-MS/MS is not foolproof, however, and requires care in operation and in the interpretation of results. 4 Except in the case of heavy cannabis use, where urine testing may give positive results 3-4 weeks post-exposure because inactive metabolites have long plasma half-lives, urine and saliva testing will only give an indication of recent (last 24-48 hr or so) drug use. Analysis of hair, on the other hand, can give information on exposure in the weeks or months prior to collection especially as regards basic drugs such as opioids, amphetamines, and cocaine. Moreover if collected with care such that the proximal (root) end is marked, segmental analysis (head hair grows on average at a rate of 1 cm/month) can reveal patterns of drug use with time depending of course on the length of the hair available for analysis. As regards assay of such samples, washing procedures are used in an attempt to remove surface contamination, and GC-or LC-MS is needed to give adequate sensitivity/selectivity (Table 12 ). All is not straightforward, however, the possibility of sample contamination prior to collection often being a major confounder in post-mortem work especially.
Occupational and Environmental Toxicology
The monitoring of occupational or environmental exposure to toxic substances is an important area. Metal ions such as lead and also some organochlorine pesticides such as chlordane and dieldrin have long half-lives in the body and thus accumulation can occur with prolonged exposure to relatively low concentrations. The manufacture of drugs can also present a hazard to those involved via (Table 13) .
Lead and lead compounds have a number of industrial uses. In blood, lead is strongly bound to erythrocytes. Accurate diagnosis and treatment of lead poisoning requires measurement of lead concentrations in EDTA whole blood. 57 Reliable blood lead measurement is technically demanding and can only be achieved with the aid of appropriate equipment and well-trained staff. Anode stripping voltammetry (ASV) is widely used for this purpose in North America, whilst in Europe electrothermal atomic absorption spectrophotometry or ICP-MS are preferred. In all cases strict adherence to internal quality control (IQC) procedures and participation in external quality assessment (EQA) or proficiency testing (PT) schemes are mandatory if reliable results are to be obtained.
Chemical incidents, i.e. unforeseen circumstances or events resulting in risk to public health from chemical poisoning, which may include release of toxic metal ions, are part of the wider continuum of safety issues ranging from water quality, and drug and food contamination, to deliberate release of toxic chemicals. Toxicological analyses can be valuable not only in providing evidence of the nature and magnitude of an exposure 58 , but also in demonstrating that no significant exposure has occurred, thereby allaying public apprehension. Clearly, the early collection of appropriate biological samples is essential. In the absence of information to the contrary it is wise to collect 10 mL whole blood (2 ϫ 5 mL EDTA) and at least 25-50 mL urine (no preservative) from exposed or possibly exposed individuals. 59 The time and date of sampling and the full name of the subject should be recorded on the samples and on a separate record sheet. The samples should be stored at either 4•C or 20 •C until the appropriate analyses can be arranged.
Laboratory Operation
Methodology adequate for certain simple tasks is described in the International Programme on Chemical Safety (IPCS)/ World Health Organization (WHO) Basic Analytical Toxicology manuaI. 60 Ideally a CO-Oximeter should also be available for carboxyhaemoglobin and methaemoglobin measurement, and there should be a simple method for lithium assay. Most drug immunoassays can be performed on standard clinical chemistry analysers.
A quantitative analysis carried out on whole blood or plasma is usually needed to confirm poisoning unequivocally, but this may not be possible if laboratory facilities are limited, or if the compound is particularly difficult to measure. It is important to discuss the scope and limitations of the tests performed with the clinician concerned and to maintain high standards of laboratory practice, especially when performing tests on an emergency basis. It may be better to offer no result rather than misleading data based on unreliable tests. Clinicians often treat poisoned patients on the basis of suspicion and history rather than await the results of a laboratory test, but may change their approach once they have the result. The treatment of paracetamol poisoning is an example.
A Quality Management system must be in operation. Quantitative assay calibration for batch analyses should be by analysis of standard solutions of each analyte (6-8 concentrations across the calibration range) prepared in, for example, analyte-free new-born calf or human serum. IQC procedures are mandatory. IQC involves the analysis of independently-prepared standard solutions of know composition that are not used in assay calibration; normally low, medium, and high concentrations of each analyte are prepared in analyte-free human serum. The analysis acceptance criteria for batch analyses should be as set out in method validation guidance. 61 Participation in EQA schemes is mandatory if there is an appropriate scheme for the analyte in question. 62 Finally, it is important to be clear as to the units used by the laboratory to report analytical results, especially if reporting to centres/hospitals that may use different units. The NPIS/ACB 2 guidelines suggest the use of SI mass units based on the litre as the unit of volume (mg L Ϫ1 , g L Ϫ1 , etc.) for reporting analytical toxicology except for lithium (and iron and other elements), thyroxine, and methotrexate, for which it is suggested that molar units -mmol L
Ϫ1
, etc. -are appropriate. This has now been adopted by consensus in the UK in clinical biochemistry. Note, however, that many scientific papers and indeed immunoassay systems from the US will tend to use SI mass units and the millilitre as the unit of volume (e.g. ng mL 
Point-of-care Testing (POCT)
An Emergency Department (ED) will have access to blood gas analysers, and these may be fitted with COOximeters thus facilitating COHb assay. Tests for other analytes such as paracetamol, salicylates, and ethanol and other drugs of abuse may also be available. Laboratory Support for the Poisoned Patient accessed 10 October 2008) draws attention to important considerations such as staff training, QA, and issues surrounding the interpretation of POCT results. 4 Some drugs of abuse POCT kits perform very poorly. 63 
Conclusions
Emergency biochemistry and haematology remain the cornerstone of laboratory support for the poisoned patent. Emergency toxicological analyses that can inf luence immediate patient management such as ethanol, iron, lithium, paracetamol, and salicylates are relatively few in number, but are nevertheless vital in ensuring appropriate treatment. In these and other instances when toxicological analyses might be requested, interpretation of the results has to be performed not only with an understanding of the clinical situation, but also with respect to the method(s) used. Operational considerations such as the time of sample collection in relation to the time course of a particular incident are also important.
